Literature DB >> 31730901

TRAF7 enhances ubiquitin-degradation of KLF4 to promote hepatocellular carcinoma progression.

Huan He1, Zhiyuan Wu1, Sheng Li2, Kun Chen1, Dongmei Wang1, Haojing Zou3, Hongyan Chen3, Yi Li3, Zhihua Liu4, Chunfeng Qu5.   

Abstract

The tumor necrosis factor receptor-associated factor 7 (TRAF7) is a component of the tumor necrosis factor alpha (TNF-α)/nuclear factor kappa B (NF-κB) pathway and is a putative E3-ubiquitin ligase. Based on importance of chronic inflammation in hepatocellular carcinoma (HCC), we investigated the biological effects and the molecular mechanisms of deregulated TRAF7 signaling in HCC. Our results showed that high TRAF7 expression in HCC samples was inversely associated with Krüppel-like factor 4 (KLF4) expression and the prognosis of HCC patients. TRAF7 could degrade KLF4 protein through ubiquitin by interacting with its N-terminus. The up-regulation of TRAF7 promoted HCC cell migration and invasion in vivo and in vitro, and TRAF7 knockdown had the opposite effects. Restoration of KLF4 abrogated the motility promotion induced by TRAF7. TRAF7 promotes HCC cell motility through inducing KLF4 protein turnover.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Liver cancer; Metastasis; Ubiquitination

Year:  2019        PMID: 31730901     DOI: 10.1016/j.canlet.2019.11.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

Review 1.  The roles of E3 ligases in Hepatocellular carcinoma.

Authors:  Zongdong Yu; Hong Li; Jie Zhu; Haibiao Wang; Xiaofeng Jin
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

2.  Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance.

Authors:  Zhuan Zhou; Xinxin Song; Junlong Jack Chi; David R Gius; Yi Huang; Massimo Cristofanilli; Yong Wan
Journal:  Cell Signal       Date:  2020-02-19       Impact factor: 4.315

3.  Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.

Authors:  Chen Xiong; Zhihuai Wang; Guifu Wang; Chi Zhang; Shengjie Jin; Guoqing Jiang; Dousheng Bai
Journal:  Invest New Drugs       Date:  2021-05-03       Impact factor: 3.850

Review 4.  Recent Discoveries on the Involvement of Krüppel-Like Factor 4 in the Most Common Cancer Types.

Authors:  Agnieszka Taracha-Wisniewska; Grzegorz Kotarba; Sebastian Dworkin; Tomasz Wilanowski
Journal:  Int J Mol Sci       Date:  2020-11-22       Impact factor: 5.923

5.  ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4.

Authors:  Jia Liu; Feng Cao; Xiaojie Li; Li Zhang; Zhengrong Liu; Xiaodong Li; Jingrong Lin; Chuanchun Han
Journal:  Cell Death Dis       Date:  2021-05-02       Impact factor: 8.469

6.  UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.

Authors:  Zhan Shi; Runkun Liu; Qiliang Lu; Zhi Zeng; Yang Liu; Junjun Zhao; Xin Liu; Lijie Li; Hui Huang; Yingmin Yao; Dongsheng Huang; Qiuran Xu
Journal:  Int J Med Sci       Date:  2021-10-11       Impact factor: 3.738

7.  FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma.

Authors:  Liang Wang; Caiyan Shi; Jie Yu; Yilin Xu
Journal:  Cancer Cell Int       Date:  2022-01-29       Impact factor: 5.722

8.  DUB3/KLF4 combats tumor growth and chemoresistance in hepatocellular carcinoma.

Authors:  Xuebing Jia; Lei Li; Fan Wang; Ying Xue; Tongde Wu; Qianqian Jia; Yunhui Li; Chenming Wu; Yuping Chen; Jinhuan Wu; Yang Su; Xinshu Wang; Tao Zhuang; Xiao Dong; Jing Ling; Jian Yuan; Qi Li
Journal:  Cell Death Discov       Date:  2022-04-05

9.  USP11 degrades KLF4 via its deubiquitinase activity in liver diseases.

Authors:  Heeyoung Yang; Daeui Park; Jeongho Ryu; Tamina Park
Journal:  J Cell Mol Med       Date:  2021-06-10       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.